Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Sep;33(9):6569-6581.
doi: 10.1007/s00330-023-09577-1. Epub 2023 Apr 18.

Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: a systematic review and meta-analysis

Claudia Maestro  1 , Leire Leache  2   3 , Marta Gutiérrez-Valencia  4   5 , Luis Carlos Saiz  4   5 , Helena Gómez  6 , Maria Carmen Bacaicoa  6 , Juan Erviti  4   5
Affiliations
Meta-Analysis

Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: a systematic review and meta-analysis

Claudia Maestro et al. Eur Radiol. 2023 Sep.

Abstract

Objectives: N-Acetylcysteine (NAC) may confer protection against post-contrast acute kidney injury (PC-AKI), although evidence is sparse and conflicting. The objective was to analyse the evidence on the efficacy and safety of NAC vs no administration of NAC in preventing PC-AKI in patients with pre-existing kidney impairment undergoing a non-interventional radiological examination requiring intravenous (IV) contrast media (CM) administration.

Methods: We carried out a systematic review including randomised controlled trials (RCTs) published in MEDLINE, EMBASE, and Clinicaltrials.gov up to May 2022. The primary outcome was PC-AKI. Secondary outcomes included the requirement of renal replacement therapy, all-cause mortality, serious adverse events, and length of hospital stay. We conducted the meta-analyses using the Mantel-Haenszel method and following a random-effects model.

Results: NAC was not associated with a significant reduction in PC-AKI (RR 0.47, 95%CI 0.20 to 1.11; 8 studies; 545 participants; I2: 56%; low certainty), all-cause mortality (RR 0.67, 95%CI 0.29 to 1.54; 2 studies; 129 participants; very low certainty), or length of hospital stay (mean difference 9.2 days, 95%CI - 20.08 to 38.48; 1 study; 42 participants; very low certainty). The impact on other outcomes could not be determined.

Conclusions: NAC may not reduce the risk of PC-AKI or all-cause mortality in people with kidney impairment who receive an IV CM prior to radiological imaging, although the certainty of the evidence is very low or low.

Clinical relevance statement: Our review concludes that prophylactic administration of N-acetylcysteine may not significantly reduce the risk of acute kidney injury in patients with kidney impairment receiving an intravenous contrast media prior to non-interventional radiological imaging, which may support decision making in this common clinical scenario.

Key points: • N-Acetylcysteine may not significantly reduce the risk of acute kidney injury in patients with kidney impairment receiving an intravenous contrast media prior to non-interventional radiological imaging. • All-cause mortality and length of hospital stay would not be decreased with the administration of N-Acetylcysteine in this setting.

Keywords: Acetylcysteine; Acute kidney injury; Contrast media; Radiology; Systematic review.

PubMed Disclaimer

References

    1. van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors. Eur Radiol 28:2845–2855 - DOI - PubMed - PMC
    1. Carbonell N, Sanjuán R, Blasco M, Jordá A, Miguel A (2010) N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients. Rev Esp Cardiol 63:12–19
    1. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent–induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184
    1. Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380:2146–2155 - DOI - PubMed
    1. Luis J, Morales F (2017) Actualidad en nefropatía por medio de contraste. Nefrología Latinoamericana Actualidad en nefropatía por medio de contraste. Nefrol Latinoam 14:69–78 - DOI

MeSH terms